These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4174657)

  • 21. [Anvitoff in hematuria].
    Besenbeck F
    Z Allgemeinmed; 1973 Dec; 49(34):1714-5. PubMed ID: 4789430
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on urokinase excretion in kidney diseases].
    Kropp R; Frey J; Jürgens J
    Med Klin; 1967 Dec; 62(50):1941-5. PubMed ID: 4873940
    [No Abstract]   [Full Text] [Related]  

  • 23. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 24. [Coagulation physiological bases of antifibrinolytic treatment in prostatectomies].
    Neef H; Preusser KP; Anger G; Richter M
    Zentralbl Chir; 1967 Apr; 92(13):486-90. PubMed ID: 5591468
    [No Abstract]   [Full Text] [Related]  

  • 25. AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding.
    Andersson L; Nilsson IM
    Scand J Urol Nephrol; 1969; 3(3):169-76. PubMed ID: 5393836
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Nov; 108(11):655-75 contd. PubMed ID: 5378688
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influencing of hematuria, following prostatectomy, by p-aminomethylbenzoic acid (PAMBA)].
    Preusser KP; Neef H; Anger G
    Langenbecks Arch Chir; 1967; 317(2):117-23. PubMed ID: 6082920
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis.
    Lakhani A; Raptis A; Frame D; Simpson D; Berkahn L; Mellon-Reppen S; Klingemann H
    Bone Marrow Transplant; 1999 Dec; 24(11):1259-60. PubMed ID: 10642819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High obstruction of urine flow as a complication of the treatment with fibrinolysis inhibitors of haematuria in haemophiliacs.
    van Itterbeek H; Vermylen J; Verstraete M
    Acta Haematol; 1968 Apr; 39(4):237-42. PubMed ID: 4969152
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of fibrinolytic and antifibrinolytic therapy on the dissemination of experimental tumours.
    Rudenstam CM
    Bibl Anat; 1967; 9():418-24. PubMed ID: 4226503
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hypoinosis and the excess of urinary urokinase in a case of "essential hematuria"].
    Barbui T; Di Luzio V; Poli D; Romagnoli GF
    G Clin Med; 1968 Apr; 49(4):371-82. PubMed ID: 5742994
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hematuria due to increased urokinase activity. Its successful treatment with p-aminomethylbenzoic acid (PAMBA)].
    Sundermann A; Vogel G
    Munch Med Wochenschr; 1965 Oct; 107(41):2003-6. PubMed ID: 5898922
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 35. The fibrinolytic activity in the urine by sephadex gel filtration.
    Sugiura H
    Nagoya Med J; 1969 Apr; 15(1):1-17. PubMed ID: 5801907
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical significance of the use of antifibrinolytic agents].
    Czuczor H; Vecsey D; Bánkuti P
    Orv Hetil; 1969 Apr; 110(17):966-9. PubMed ID: 5305356
    [No Abstract]   [Full Text] [Related]  

  • 37. Amicar and hyperfibrinolysis.
    Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenetic prerequisites for the use of drugs regulating mechanisms of blood coagulation and fibrinolysis in ophthalmology.
    Trutneva KV; Tartakovskaja AI; Mikhailova NA; Poliakova LY
    Bull Ophthalmol Soc Egypt; 1974; 67():397-404. PubMed ID: 4466553
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of intravenous injections of antifibrinolytic agents on the local fibrinolytic activators in the human vagina].
    Herschlein HJ; Steichele DF
    Zentralbl Gynakol; 1970 Dec; 92(49):1624-7. PubMed ID: 5500076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.